126 related articles for article (PubMed ID: 25103076)
1. Volume changes in remnant thyroid tissue after thyroidectomy in Graves disease.
Chen PY; Chao CM; Wu TJ; Huang SM
J Formos Med Assoc; 2014 Sep; 113(9):629-33. PubMed ID: 25103076
[TBL] [Abstract][Full Text] [Related]
2. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.
Sugino K; Mimura T; Toshima K; Iwabuchi H; Kitamura Y; Kawano M; Ozaki O; Ito K
J Endocrinol Invest; 1993 Mar; 16(3):195-9. PubMed ID: 8099920
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluations of subtotal thyroidectomy for Graves' disease].
Takai Y
Nihon Naibunpi Gakkai Zasshi; 1995 Jan; 71(1):27-38. PubMed ID: 7895863
[TBL] [Abstract][Full Text] [Related]
4. Thyroid morphology and function after surgical treatment of thyroid diseases.
Mann B; Schmale P; Stremmel W
Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: case control study by remnant-weight matched-pair analysis.
Ozaki O; Ito K; Mimura T; Sugino K; Ito K
Thyroid; 1997 Aug; 7(4):555-9. PubMed ID: 9292942
[TBL] [Abstract][Full Text] [Related]
6. [Unfavorable characteristics in patients with early postoperative recurrence of Graves' disease after subtotal thyroidectomy].
Okamoto T; Fujimoto Y; Obara T; Ito Y; Iihara M; Kanaji Y; Yamashita T
Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):1043-6. PubMed ID: 8246868
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting thyroid function after thyroidectomy for Graves' disease.
Huang CS; Wang M; Shun CT; Liaw KY
J Formos Med Assoc; 1995 Jul; 94(7):423-7. PubMed ID: 7549568
[TBL] [Abstract][Full Text] [Related]
8. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
Goto A; Uchino S; Noguchi S; Wakiya S; Watanabe Y; Murakami T; Matsuura B; Onji M
Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
[TBL] [Abstract][Full Text] [Related]
9. [Subtotal resection of thyroid gland - optimal method for threatment of Bazedow disease. Prognosis].
Kŭtev N; Petkov R; Iarŭmov N
Khirurgiia (Sofiia); 2007; (3):9-13. PubMed ID: 18437102
[TBL] [Abstract][Full Text] [Related]
10. [Intraoperative ultrasonic evaluation of the residual thyroid weight in thyroidectomy in diffuse toxic goiter].
Bongarzoni G; Pierfelice A; Fossaceca R; Massari R
Chir Ital; 1994; 46(4):73-4. PubMed ID: 7882449
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
[TBL] [Abstract][Full Text] [Related]
12. Preoperative administration of excess iodide increases thyroid volume of patients with Graves' disease.
Yabuta T; Ito Y; Hirokawa M; Fukushima M; Inoue H; Tomoda C; Higashiyama T; Kihara M; Uruno T; Takamura Y; Kobayashi K; Miya A; Matsuzuka F; Miyauchi A
Endocr J; 2009; 56(3):371-5. PubMed ID: 19139595
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of surgical treatment of Graves' disease].
Kasuga Y; Sugenoya A; Kobayashi S; Kaneko G; Masuda H; Iida F
Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):423-8. PubMed ID: 2770684
[TBL] [Abstract][Full Text] [Related]
14. Determination of remnant thyroid volume: comparison of ultrasonography, radioactive iodine uptake and serum thyroid-stimulating hormone level.
Erbil Y; Barbaros U; Salmaslioglu A; Issever H; Tukenmez M; Adalet I; Bozbora A; Ozarmagan S; Tezelman S
J Laryngol Otol; 2008 Jun; 122(6):615-22. PubMed ID: 17605833
[TBL] [Abstract][Full Text] [Related]
15. The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
Erbil Y; Giriş M; Salmaslioglu A; Ozluk Y; Barbaros U; Yanik BT; Kapran Y; Abbasoglu SD; Ozarmagan S
Surgery; 2008 Feb; 143(2):216-25. PubMed ID: 18242338
[TBL] [Abstract][Full Text] [Related]
16. [Basedow disease. From subtotal to total thyroidectomy].
Gemsenjäger E; Valko P; Schweizer I
Praxis (Bern 1994); 2002 Feb; 91(6):206-15. PubMed ID: 11875842
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the response to surgical treatment of Graves' disease.
Kasuga Y; Sugenoya A; Kobayashi S; Kaneko G; Masuda H; Fujimori M; Iida F
Surg Gynecol Obstet; 1990 Apr; 170(4):327-30. PubMed ID: 2321125
[TBL] [Abstract][Full Text] [Related]
18. The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves disease.
Huang SM; Chow NH; Lee HL; Wu TJ
Arch Surg; 2003 Feb; 138(2):146-51; discussion 151. PubMed ID: 12578408
[TBL] [Abstract][Full Text] [Related]
19. Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies.
Kawai K; Tamai H; Mori T; Morita T; Matsubayashi S; Katayama S; Kuma K; Kumagai LF
J Clin Endocrinol Metab; 1993 Sep; 77(3):716-9. PubMed ID: 7690362
[TBL] [Abstract][Full Text] [Related]
20. Surgery still has a role in Graves' hyperthyroidism.
Patwardhan NA; Moront M; Rao S; Rossi S; Braverman LE
Surgery; 1993 Dec; 114(6):1108-12; discussion 1112-3. PubMed ID: 8256215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
